Health Care Sector Update for 11/21/2018: SYN, CYAD, JNJ, PFE, ABT, MRK, AMGN
Top Health Care Stocks:
Health care stocks were narrowly mixed pre-market Wednesday.
Early movers include:
(+) Synthetic Biologics ( SYN ), which was surging more than 18% as the company said it successfully completed an end-of-phase 2 meeting with the US Food and Drug Administration on its ribaxamase for the prevention of Clostridium difficile infection.
In other sector news:
(-) The US Court of Appeals for the Federal Circuit denied Johnson & Johnson’s ( JNJ ) request to block low-cost versions of Zytinga from entering the US market while the pharmaceutical firm appeals a trial judge’s ruling that invalidated a patent on the blockbuster colorectal cancer drug, Bloomberg News reported. Johnson & Johnson stock was slightly lower in recent trading.
(=) Celyad SA ( CYAD ) was unchanged as it reported cash, cash equivalents, and short-term investments of EUR55.9 million ($63.73 million) as part of a Q3 business update.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.
Zeen is a next generation WordPress theme. It’s powerful, beautifully designed and comes with everything you need to engage your visitors and increase conversions.
Go to Appearance > Customize > Subscribe Pop-up to set this up.
Wealth Empire Newsletter
Register now for free updates and alerts
Note: I have the ability to revoke this permission at any time and ask for the removal of my personal data collected by contacting us or simply clicking Unsubscribe.